Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study

Fig. 2

Median glucose levels measured by CGM throughout 24 h at week 0 and week 24 (A). Gray and black lines show levels at week 0 and week 24, respectively. The thick line in the middle shows the median, and the lines below and above the median show 25th and 75th percentiles, respectively. Changes in 1 and 2 h postprandial glucose excursions assessed by CGM (B). **P < 0.01 versus baseline (week 0)

Back to article page